Neurotrope Issues Statement On Eli Lilly's Solanezumab
Go back to Neurotrope Issues Statement On Eli Lilly's Solanezumab| Neurotrope, Inc. Common (NASDAQ: NTRP) | Delayed: 2.18 -0.05 (2.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.23 | 52 Week High | $0.80 | |||
| Open | $2.25 | 52 Week Low | $0.20 | |||
| Day High | $2.25 | P/E | N/A | |||
| Day Low | $2.13 | EPS | $0.00 | |||
| Volume | 14,752 | |||||
